Oxford University Innovation
Edit

Oxford University Innovation

https://www.innovation.ox.ac.uk/
Last activity: 23.07.2026
Active
Invests in categories: BioTechDataDevelopmentHealthTechMedTechPlatformQuantumSoftwareTechnologyUniversity
Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner.

Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society.

We support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact.
Portfolio
203
Persons
48
Mentions
34
Location: United Kingdom, England, Oxford
Employees: 51-200
Founded date: 1987
Investment Stage: Seed; Series A
.

Portfolio 203

DateNameWebsiteTotal RaisedLocation
23.07.2026MOA Techno...moa-technology.com$82MUnited Kin...
12.02.2026Astutastut.co.uk--
14.11.2025Scripta Th...scriptatherapeutics.com$12.05MUnited Kin...
01.11.2025Macrocosmmacrocosm.group--
01.11.2025Vivid Dx (...vivid-dx.com--
01.11.2025Oxaoxa.tech$243MUnited Kin...
23.02.2025Mode Labsmodelabs.tech--
26.01.2025Greater Ch...greaterchange.co.uk-United Kin...
26.01.2025OpenClinic...openclinical.net--
26.01.2025Nature-bas...naturebasedinsights.com--
Show more

Persons 48

DateFirst NameLast NameTitleLinkedInLocation
-AnnaHerzbergOperations...-
-ClareHuggardDeputy Hea...-
-ClaireHewittPA to CEO-
-AdamMinshallSenior Lic...-
-VivParryPeople &am...-
-AmberHarrisonInvestor R...-
-BethanyBonwickUniversity...-
-GurinderPunnSenior Pro...-
-RachelWilsonConsulting...-
-RebeccaGlenappLicensing ...-
Show more

Mentions in press and media 34

DateTitleDescription
29.07.2026Moa Technology Secures $29.6M, Redefines Global Weed ControlMoa Technology, a UK innovator, secured a $29.6 million Series C round. This funding targets urgent global agricultural challenges. Herbicide-resistant weeds plague farms worldwide. Moa develops revolutionary solutions. It discovers novel m...
23.07.2026Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova InvestOXFORD, England, July 23, 2026 /PRNewswire/ -- Moa Technology ("Moa"), an agricultural biotechnology company focused on discovering novel mode of action herbicides, announces a £22.2 million Series C financing round, co-led by Oxf...
23.07.2026Moa Technology raises $30m to advance novel modes of action in weed managementUK-based Moa Technology has raised a £22.2 million ($29.6 million) Series C round to further advance its discovery platform for novel modes of action in weed management. The company, which spun out of Oxford University in 2017, says it has ...
22.05.2026Cambridge Wide Open Week 2026 announces top-tier keynotes & participating ventures for new expanded formatCambridge Wide Open Week 2026 has unveiled further details of its highly anticipated June 11–19 event as the life sciences festival expands across the UK’s innovation “Golden Triangle” for the very first time. Keynote speakers for the event...
30.03.2026CWOW 2026: Cambridge’s life sciences showcase expands to Oxford & LondonCambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time. The Cambridge-Oxford-London corridor is widely regarded as one of th...
03.12.2025ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge ModelILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced the peer-reviewed publication of Phase 2b trial results in The...
16.11.2025Scripta Therapeutics Transforms Disease Treatment with $12M InvestmentScripta Therapeutics, an Oxford-based techbio startup, has raised $12 million in seed funding. This capital propels its innovative biology-first platform. The system leverages AI, advanced imaging, and patient-derived models. It precisely t...
14.11.2025Scripta Therapeutics Raises $12M in Seed FundingScripta Therapeutics, an Oxford, UK-based techbio startup, raised $12m in seed funding. The round was led by Oxford Science Enterprises and Apollo Health Ventures, with participation from AlbionVC, YZR Capital, and Parkwalk Advisors, and su...
12.11.2025The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discoveryOxford BioTech startup Scripta Therapeutics emerges from stealth today by announcing a €10.3 million ($12 million) Seed round to upend conventional approaches to drug discovery. The round is led jointly by Oxford Science Enterprises (OSE) a...
23.09.2025DaltonTx lands £4M to advance the intelligence backbone of drug discoveryUK-based technology company DaltonTx has exited stealth and completed a £4 million seed financing round. Backed by Redalpine, IQ Capital Partners, and Seedcamp, with additional support from Oxford University Innovation, DaltonTx will use th...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In